Search

everythinglearnresearchcommunity

for

Search:↓

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Low testosterone increases kidney stone risk in men not on testosterone therapy.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Nocturia cases increased, but medication use declined, suggesting under-treatment.

Systemic therapy may reduce male infertility in psoriasis patients.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Semaglutide does not significantly increase the risk of hair loss.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Pregnancy skin issues can lead to complications, seborrheic dermatitis is linked to STDs, community education helps homeless women's skin, topical timolol is safe for infant hemangiomas, synthetic progestins affect melasma risk, and hijab-related hair loss affects mental health, with cultural barriers limiting treatment access.

Low-dose oral minoxidil does not significantly affect blood pressure in patients with hair loss and hypertension.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

Dupilumab users have a higher risk of developing alopecia areata.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.

People with hidradenitis suppurativa have a higher risk of kidney stones.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

Long-COVID has diverse, long-term health impacts, especially in young people.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

GLP-1 agonists may help treat certain skin conditions.

Alopecia areata patients often face mental health issues like anxiety and depression.

Low-dose finasteride may increase erectile dysfunction risk over time.

Spironolactone can safely lower blood pressure in patients on other blood pressure medications, but may slightly increase the risk of low blood pressure.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

New and repurposed treatments are improving outcomes in dermatology.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.